These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 19262496

  • 1. Inhibition of the renin-angiotensin system and target organ protection.
    Iwanami J, Mogi M, Iwai M, Horiuchi M.
    Hypertens Res; 2009 Apr; 32(4):229-37. PubMed ID: 19262496
    [Abstract] [Full Text] [Related]

  • 2. [Blockade of the renin-angiotensin system by a combination of ACE inhibitors and AT1 receptor antagonists].
    Azizi M.
    Rev Prat; 2004 Jun 15; 54(11):1167-74. PubMed ID: 15496022
    [Abstract] [Full Text] [Related]

  • 3. Continuous inhibition of the renin-angiotensin system and protection from hypertensive end-organ damage by brief treatment with angiotensin II type 1 receptor blocker in stroke-prone spontaneously hypertensive rats.
    Takemori K, Ishida H, Ito H.
    Life Sci; 2005 Sep 16; 77(18):2233-45. PubMed ID: 15963533
    [Abstract] [Full Text] [Related]

  • 4. The evolving story of the RAAS in hypertension, diabetes and CV disease: moving from macrovascular to microvascular targets.
    Steckelings UM, Rompe F, Kaschina E, Unger T.
    Fundam Clin Pharmacol; 2009 Dec 16; 23(6):693-703. PubMed ID: 19817870
    [Abstract] [Full Text] [Related]

  • 5. RAS inhibition in hypertension.
    Ibrahim MM.
    J Hum Hypertens; 2006 Feb 16; 20(2):101-8. PubMed ID: 16397519
    [Abstract] [Full Text] [Related]

  • 6. Establishing a new option for target-organ protection: rationale for ARB plus ACE inhibitor combination therapy.
    Cohn JN, Goldman JM.
    Am J Hypertens; 2008 Mar 16; 21(3):248-56. PubMed ID: 18219303
    [Abstract] [Full Text] [Related]

  • 7. Blocking the renin-angiotensin system: dual- versus mono-therapy.
    Ravandi A, Teo KK.
    Expert Rev Cardiovasc Ther; 2009 Jun 16; 7(6):667-74. PubMed ID: 19505282
    [Abstract] [Full Text] [Related]

  • 8. Emerging concepts in antihypertensive therapy: the benefits of angiotensin II blockade.
    Meggs LG, Kodali P.
    J Assoc Acad Minor Phys; 1999 Jun 16; 10(2):34-43. PubMed ID: 10826007
    [Abstract] [Full Text] [Related]

  • 9. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
    Abassi Z, Armaly Z, Nakhoul F, Hoffman A.
    Harefuah; 2008 Jun 16; 147(6):536-42, 573. PubMed ID: 18693632
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological properties of angiotensin II antagonists: examining all the therapeutic implications.
    Unger T.
    J Renin Angiotensin Aldosterone Syst; 2001 Sep 16; 2 Suppl 2():S4-7. PubMed ID: 11881101
    [Abstract] [Full Text] [Related]

  • 11. Effect of the renin--angiotensin system on the vessel wall: using ACE inhibition to improve endothelial function.
    Neutel JM.
    J Hum Hypertens; 2004 Sep 16; 18(9):599-606. PubMed ID: 15190263
    [Abstract] [Full Text] [Related]

  • 12. Tissue renin-angiotensin systems. Their role in cardiovascular disease.
    Lee MA, Böhm M, Paul M, Ganten D.
    Circulation; 1993 May 16; 87(5 Suppl):IV7-13. PubMed ID: 8485836
    [Abstract] [Full Text] [Related]

  • 13. The renin-angiotensin system: importance in physiology and pathology.
    Ferrario CM.
    J Cardiovasc Pharmacol; 1990 May 16; 15 Suppl 3():S1-5. PubMed ID: 1691411
    [Abstract] [Full Text] [Related]

  • 14. The role of the renin-angiotensin-aldosterone system in diabetes and its vascular complications.
    Cooper ME.
    Am J Hypertens; 2004 Nov 16; 17(11 Pt 2):16S-20S; quiz A2-4. PubMed ID: 15539106
    [Abstract] [Full Text] [Related]

  • 15. [The current concept of the renin-angiotensin system].
    Ibarra-Rubio ME, Pedraza-Chaverrí J.
    Rev Invest Clin; 1993 Nov 16; 45(2):165-77. PubMed ID: 8337545
    [Abstract] [Full Text] [Related]

  • 16. Effects of angiotensin II receptor blockers on dementia.
    Mogi M, Horiuchi M.
    Hypertens Res; 2009 Sep 16; 32(9):738-40. PubMed ID: 19727113
    [Abstract] [Full Text] [Related]

  • 17. Pharmacological interferences with the renin-angiotensin system.
    Ganten D, Unger T, Lang RE.
    Arzneimittelforschung; 1984 Sep 16; 34(10B):1391-8. PubMed ID: 6097263
    [Abstract] [Full Text] [Related]

  • 18. Direct renin inhibition with aliskiren in hypertension and target organ damage.
    Müller DN, Luft FC.
    Clin J Am Soc Nephrol; 2006 Mar 16; 1(2):221-8. PubMed ID: 17699210
    [Abstract] [Full Text] [Related]

  • 19. [Rationale for the use of renin-angiotensin inhibitors in the treatment of arterial hypertension and correlated organ damage].
    Mammarella A, Paoletti V, De Matteis A, Di Franco M, Cavina G, Paradiso M.
    Clin Ter; 2002 Mar 16; 153(1):45-9. PubMed ID: 11963634
    [Abstract] [Full Text] [Related]

  • 20. The therapeutic role of RAS blockade in chronic heart failure.
    Werner CM, Böhm M.
    Ther Adv Cardiovasc Dis; 2008 Jun 16; 2(3):167-77. PubMed ID: 19124420
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.